Standardization of Laboratory and Lipid Profile Evaluation: a Call for Action with a Special Focus in 2016 ESC/EAS Dyslipidaemia Guidelines - Full Report
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.17/3365 |
Resumo: | Even with the improvement in lifestyle interventions, a better control of cardiovascular (CV) risk factors, and improvements in CV outcomes, cardiovascular disease (CVD) still persists as the leading cause of morbidity and mortality in Portugal and Europe. Atherogenic dyslipidaemias, namely hypercholesterolaemia, have a crucial and causal role in the development of atherosclerotic CVD. The clinical approach of a patient with dyslipidaemia involves a watchful diagnosis, sustained in lipid and lipoprotein laboratory procedures, which must be harmonized and standardized. Standardization of lipid test results and reports, incorporating the total CV risk and the respective target and goals of treatment approach, guarantees that clinical guidelines and good clinical practices are followed and respected, increasing the reliability of lipid disorders screening, producing more accurate diagnoses and CV risk stratification, and improving the CV prevention and the achievement the desirable treatment goals. |
id |
RCAP_f57cbaa098369420ec4d6c413903e7eb |
---|---|
oai_identifier_str |
oai:repositorio.chlc.min-saude.pt:10400.17/3365 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Standardization of Laboratory and Lipid Profile Evaluation: a Call for Action with a Special Focus in 2016 ESC/EAS Dyslipidaemia Guidelines - Full ReportBiomarkersBlood Chemical AnalysisCardiovascular DiseasesConsensusDyslipidemiasFastingHumansLipidsLipoproteinsPortugalPredictive Value of TestsPrognosisReproducibility of ResultsRisk AssessmentRisk FactorsHSM MEDEven with the improvement in lifestyle interventions, a better control of cardiovascular (CV) risk factors, and improvements in CV outcomes, cardiovascular disease (CVD) still persists as the leading cause of morbidity and mortality in Portugal and Europe. Atherogenic dyslipidaemias, namely hypercholesterolaemia, have a crucial and causal role in the development of atherosclerotic CVD. The clinical approach of a patient with dyslipidaemia involves a watchful diagnosis, sustained in lipid and lipoprotein laboratory procedures, which must be harmonized and standardized. Standardization of lipid test results and reports, incorporating the total CV risk and the respective target and goals of treatment approach, guarantees that clinical guidelines and good clinical practices are followed and respected, increasing the reliability of lipid disorders screening, producing more accurate diagnoses and CV risk stratification, and improving the CV prevention and the achievement the desirable treatment goals.ElsevierRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEMarques da Silva, PSequeira Duarte, Jvon Hafe, PGil, VNunes de Oliveira, Jde Sousa, G2019-11-22T16:40:25Z2018-062018-06-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/3365engAtheroscler Suppl. 2018 Jun;31:e1-e12.10.1016/j.atherosclerosissup.2018.04.001info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:42:38Zoai:repositorio.chlc.min-saude.pt:10400.17/3365Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:20:40.964837Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Standardization of Laboratory and Lipid Profile Evaluation: a Call for Action with a Special Focus in 2016 ESC/EAS Dyslipidaemia Guidelines - Full Report |
title |
Standardization of Laboratory and Lipid Profile Evaluation: a Call for Action with a Special Focus in 2016 ESC/EAS Dyslipidaemia Guidelines - Full Report |
spellingShingle |
Standardization of Laboratory and Lipid Profile Evaluation: a Call for Action with a Special Focus in 2016 ESC/EAS Dyslipidaemia Guidelines - Full Report Marques da Silva, P Biomarkers Blood Chemical Analysis Cardiovascular Diseases Consensus Dyslipidemias Fasting Humans Lipids Lipoproteins Portugal Predictive Value of Tests Prognosis Reproducibility of Results Risk Assessment Risk Factors HSM MED |
title_short |
Standardization of Laboratory and Lipid Profile Evaluation: a Call for Action with a Special Focus in 2016 ESC/EAS Dyslipidaemia Guidelines - Full Report |
title_full |
Standardization of Laboratory and Lipid Profile Evaluation: a Call for Action with a Special Focus in 2016 ESC/EAS Dyslipidaemia Guidelines - Full Report |
title_fullStr |
Standardization of Laboratory and Lipid Profile Evaluation: a Call for Action with a Special Focus in 2016 ESC/EAS Dyslipidaemia Guidelines - Full Report |
title_full_unstemmed |
Standardization of Laboratory and Lipid Profile Evaluation: a Call for Action with a Special Focus in 2016 ESC/EAS Dyslipidaemia Guidelines - Full Report |
title_sort |
Standardization of Laboratory and Lipid Profile Evaluation: a Call for Action with a Special Focus in 2016 ESC/EAS Dyslipidaemia Guidelines - Full Report |
author |
Marques da Silva, P |
author_facet |
Marques da Silva, P Sequeira Duarte, J von Hafe, P Gil, V Nunes de Oliveira, J de Sousa, G |
author_role |
author |
author2 |
Sequeira Duarte, J von Hafe, P Gil, V Nunes de Oliveira, J de Sousa, G |
author2_role |
author author author author author |
dc.contributor.none.fl_str_mv |
Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE |
dc.contributor.author.fl_str_mv |
Marques da Silva, P Sequeira Duarte, J von Hafe, P Gil, V Nunes de Oliveira, J de Sousa, G |
dc.subject.por.fl_str_mv |
Biomarkers Blood Chemical Analysis Cardiovascular Diseases Consensus Dyslipidemias Fasting Humans Lipids Lipoproteins Portugal Predictive Value of Tests Prognosis Reproducibility of Results Risk Assessment Risk Factors HSM MED |
topic |
Biomarkers Blood Chemical Analysis Cardiovascular Diseases Consensus Dyslipidemias Fasting Humans Lipids Lipoproteins Portugal Predictive Value of Tests Prognosis Reproducibility of Results Risk Assessment Risk Factors HSM MED |
description |
Even with the improvement in lifestyle interventions, a better control of cardiovascular (CV) risk factors, and improvements in CV outcomes, cardiovascular disease (CVD) still persists as the leading cause of morbidity and mortality in Portugal and Europe. Atherogenic dyslipidaemias, namely hypercholesterolaemia, have a crucial and causal role in the development of atherosclerotic CVD. The clinical approach of a patient with dyslipidaemia involves a watchful diagnosis, sustained in lipid and lipoprotein laboratory procedures, which must be harmonized and standardized. Standardization of lipid test results and reports, incorporating the total CV risk and the respective target and goals of treatment approach, guarantees that clinical guidelines and good clinical practices are followed and respected, increasing the reliability of lipid disorders screening, producing more accurate diagnoses and CV risk stratification, and improving the CV prevention and the achievement the desirable treatment goals. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-06 2018-06-01T00:00:00Z 2019-11-22T16:40:25Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.17/3365 |
url |
http://hdl.handle.net/10400.17/3365 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Atheroscler Suppl. 2018 Jun;31:e1-e12. 10.1016/j.atherosclerosissup.2018.04.001 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799131302707855360 |